HSP90AA1 and Alzheimer disease: observed a significantly lower level of acetylated HSP90 (acetyl-HSP90) in PBMCs from AD patients compared to controls, while treatment of human keratinocytes (HaCaT cells) with 17-AAG led to increased acetylation of HSP90.